The score is held back primarily by very weak and volatile profitability (including a large 2025 net loss) and inconsistent cash generation (FCF at zero in 2025). Technicals also detract, with the price below all key moving averages and negative MACD. Balance-sheet strength (minimal debt, large equity base) provides partial support, but valuation is not favorable/clear due to the negative P/E and no dividend yield data.
Positive Factors
Balance sheet strength
Minimal debt and a large equity base (~4.4bn) materially reduce financial distress risk, giving Linc patient capital to support portfolio companies and absorb valuation swings. This structural conservatism preserves optionality for long-term exits and follow-on funding.
Specialized life-science focus
A narrow, sector-focused strategy creates durable competitive advantages: domain expertise, concentrated deal flow, and the ability to actively support portfolio companies. Over months, specialized support and networks can improve exit outcomes and drive value creation.
Revenue rebound & strong gross margin
The 2025 revenue recovery and high gross margin indicate the firm's capacity to generate profitable operating income from parts of its portfolio. If sustained, this improves structural cash generation potential and reduces sole reliance on timing of exits.
Negative Factors
Earnings volatility and large loss
Extreme multi-year profit volatility and the sizeable 2025 net loss undermine earnings predictability and can erode shareholder equity. Persistent swings complicate planning, dividend prospects, and investor returns, increasing execution and reputation risk for an investment vehicle.
Uneven cash generation
Inconsistent operating cash flow and a drop to zero FCF in 2025 reduce financial flexibility to fund follow-on investments or support portfolio firms without selling assets. Structural cash volatility raises the probability of forced monetization at unfavorable times.
Business model reliant on portfolio returns
Revenue and cash flow depend on exits, valuation uplifts, and dividend timing from holdings. This structural dependence on external liquidity events and market valuations produces persistent unpredictability in income and makes sustained organic revenue generation unlikely.
Linc AB (LINC) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr3.94B
Dividend YieldN/A
Average Volume (3M)47.06K
Price to Earnings (P/E)―
Beta (1Y)0.69
Revenue Growth45733.33%
EPS Growth-105.08%
CountrySE
Employees2
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)-1.87
Shares Outstanding57,910,446
10 Day Avg. Volume58,577
30 Day Avg. Volume47,060
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.91
Price to Sales (P/S)415.95
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Linc AB Business Overview & Revenue Model
Company DescriptionLinc AB is a private equity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.private eequity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.
How the Company Makes MoneyLinc AB makes money primarily through returns on its investment portfolio rather than by selling operating products or services itself. Key sources of earnings typically include: (1) value appreciation of its holdings in portfolio companies (reflected in changes in the fair value/market value of listed and unlisted investments); (2) realized gains when Linc exits or partially sells holdings (e.g., through trade sales, secondary sales, or IPOs of portfolio companies); and (3) dividends and other distributions received from portfolio companies when those companies generate distributable profits. The company’s results and cash generation are therefore driven by portfolio performance, timing and pricing of exits, and the ability of underlying holdings to pay dividends. Specific material partnerships, fee-based revenue streams, or other recurring operating revenues are null.
Linc AB Financial Statement Overview
Summary
Low leverage and a large equity base support resilience (debt-to-equity ~0; equity ~4.4bn), but performance quality is weak due to extreme earnings volatility. 2025 showed strong revenue growth (~+76% to ~9.7m) and solid gross margin (~65%) yet a very large net loss (~-399.6m). Cash generation is uneven, with free cash flow falling to zero in 2025 and multi-year operating cash flow volatility.
Income Statement
34
Negative
Results are highly volatile. Revenue rebounded sharply in 2025 (up ~76% to ~9.7m) with a solid gross profit margin (~65%), but profitability collapsed with a very large net loss (~-399.6m) and deeply negative operating profitability. Prior years swing between unusually large profits (2020, 2023, 2024) and sizeable losses (2021, 2022, 2025), making earnings quality and predictability weak despite occasional strong profit years.
Balance Sheet
78
Positive
Balance sheet is conservatively financed with essentially no debt (debt-to-equity ~0), which reduces financial risk. Equity remains very large (~4.4bn in 2025), though it declined versus 2024, consistent with the latest-year loss. Returns to shareholders are inconsistent, swinging from strong positive years (2020/2023/2024) to meaningfully negative years (2022/2025).
Cash Flow
45
Neutral
Cash generation is mixed. Operating cash flow was positive in 2024 (~29.7m) and modestly positive in 2025 (~4.3m), but was materially negative in 2021–2023, indicating uneven cash conversion across cycles. Free cash flow fell to zero in 2025 (down 100% from 2024), reducing financial flexibility, even though the company did not appear to rely on leverage.
Breakdown
Dec 2025
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Income Statement
Total Revenue
9.70M
0.00
3.65M
2.37M
4.14M
Gross Profit
6.29M
-7.88M
-1.89M
-2.66M
-2.44M
EBITDA
-406.77M
1.30B
666.10M
-895.91M
-36.93M
Net Income
-399.65M
1.30B
619.46M
-723.34M
-30.03M
Balance Sheet
Total Assets
4.44B
4.84B
3.53B
2.91B
3.76B
Cash, Cash Equivalents and Short-Term Investments
283.98M
549.66M
519.98M
600.55M
828.69M
Total Debt
0.00
0.00
0.00
0.00
0.00
Total Liabilities
11.62M
8.76M
2.92M
2.85M
130.48M
Stockholders Equity
4.43B
4.83B
3.53B
2.91B
3.63B
Cash Flow
Free Cash Flow
0.00
29.68M
-80.57M
-228.15M
-353.84M
Operating Cash Flow
4.25M
29.68M
-80.57M
-228.15M
-353.84M
Investing Cash Flow
-181.93M
0.00
0.00
-199.75M
-339.45M
Financing Cash Flow
-88.00M
0.00
0.00
-5.00M
1.16B
Linc AB Technical Analysis
Technical Analysis Sentiment
Neutral
Last Price69.40
Price Trends
50DMA
65.73
Positive
100DMA
67.43
Positive
200DMA
71.29
Negative
Market Momentum
MACD
1.12
Positive
RSI
48.83
Neutral
STOCH
34.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LINC, the sentiment is Neutral. The current price of 69.4 is above the 20-day moving average (MA) of 68.94, above the 50-day MA of 65.73, and below the 200-day MA of 71.29, indicating a neutral trend. The MACD of 1.12 indicates Positive momentum. The RSI at 48.83 is Neutral, neither overbought nor oversold. The STOCH value of 34.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:LINC.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 24, 2026